Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity

Sabina Sangaletti, Claudio Tripodo, Alessandra Santangelo, Nadia Castioni, Paola Portararo, Alessandro Gulino, Laura Botti, Mariella Parenza, Barbara Cappetti, Rosaria Orlandi, Elda Tagliabue, Claudia Chiodoni, Mario P. Colombo

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

The extracellular matrix (ECM) contributes to the biological and clinical heterogeneity of breast cancer, and different prognostic groups can be identified according to specific ECM signatures. In high-grade, but not low-grade, tumors, an ECM signature characterized by high SPARC expression (ECM3) identifies tumors with increased epithelial-to-mesenchymal transition (EMT), reduced treatment response, and poor prognosis. To better understand how this ECM3 signature is contributing to tumorigenesis, we expressed SPARC in isogenic cell lines and found that SPARC overexpression in tumor cells reduces their growth rate and induces EMT. SPARC expression also results in the formation of a highly immunosuppressive microenvironment, composed by infiltrating T regulatory cells, mast cells, and myeloid-derived suppressor cells (MDSCs). The ability of SPARC to induce EMT depended on the localization and suppressive function of myeloid cells, and inhibition of the suppressive function MDSCs by administration of aminobisphosphonates could revert EMT, rendering SPARC-overexpressing tumor cells sensitive to Doxil. We conclude that that SPARC is regulating the interplay between MDSCs and the ECM to drive the induction of EMT in tumor cells.

Original languageEnglish
Pages (from-to)233-248
Number of pages16
JournalCell Reports
Volume17
Issue number1
DOIs
Publication statusPublished - Sep 27 2016

Fingerprint

Epithelial-Mesenchymal Transition
Myeloid Cells
Extracellular Matrix
Tumors
Breast Neoplasms
Cells
Neoplasms
Regulatory T-Lymphocytes
Immunosuppressive Agents
Mast Cells
Carcinogenesis
Cell Line
Growth
Myeloid-Derived Suppressor Cells

Keywords

  • aminobisphosphonates
  • Breast cancer
  • COX-2
  • CXCL12
  • cyclooxygenase-2
  • ECM
  • EMT
  • epithelial to mesenchymal transition
  • extracellular matrix
  • G-CSF
  • GM-CSF
  • granulocyte colony-stimulating factor
  • granulocyte-macrophage colony-stimulating factor
  • MDSC
  • myeloid-derived suppressor cells
  • SPARC

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity. / Sangaletti, Sabina; Tripodo, Claudio; Santangelo, Alessandra; Castioni, Nadia; Portararo, Paola; Gulino, Alessandro; Botti, Laura; Parenza, Mariella; Cappetti, Barbara; Orlandi, Rosaria; Tagliabue, Elda; Chiodoni, Claudia; Colombo, Mario P.

In: Cell Reports, Vol. 17, No. 1, 27.09.2016, p. 233-248.

Research output: Contribution to journalArticle

Sangaletti, Sabina ; Tripodo, Claudio ; Santangelo, Alessandra ; Castioni, Nadia ; Portararo, Paola ; Gulino, Alessandro ; Botti, Laura ; Parenza, Mariella ; Cappetti, Barbara ; Orlandi, Rosaria ; Tagliabue, Elda ; Chiodoni, Claudia ; Colombo, Mario P. / Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity. In: Cell Reports. 2016 ; Vol. 17, No. 1. pp. 233-248.
@article{8526dc90f4f64739974117704519c1b3,
title = "Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity",
abstract = "The extracellular matrix (ECM) contributes to the biological and clinical heterogeneity of breast cancer, and different prognostic groups can be identified according to specific ECM signatures. In high-grade, but not low-grade, tumors, an ECM signature characterized by high SPARC expression (ECM3) identifies tumors with increased epithelial-to-mesenchymal transition (EMT), reduced treatment response, and poor prognosis. To better understand how this ECM3 signature is contributing to tumorigenesis, we expressed SPARC in isogenic cell lines and found that SPARC overexpression in tumor cells reduces their growth rate and induces EMT. SPARC expression also results in the formation of a highly immunosuppressive microenvironment, composed by infiltrating T regulatory cells, mast cells, and myeloid-derived suppressor cells (MDSCs). The ability of SPARC to induce EMT depended on the localization and suppressive function of myeloid cells, and inhibition of the suppressive function MDSCs by administration of aminobisphosphonates could revert EMT, rendering SPARC-overexpressing tumor cells sensitive to Doxil. We conclude that that SPARC is regulating the interplay between MDSCs and the ECM to drive the induction of EMT in tumor cells.",
keywords = "aminobisphosphonates, Breast cancer, COX-2, CXCL12, cyclooxygenase-2, ECM, EMT, epithelial to mesenchymal transition, extracellular matrix, G-CSF, GM-CSF, granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, MDSC, myeloid-derived suppressor cells, SPARC",
author = "Sabina Sangaletti and Claudio Tripodo and Alessandra Santangelo and Nadia Castioni and Paola Portararo and Alessandro Gulino and Laura Botti and Mariella Parenza and Barbara Cappetti and Rosaria Orlandi and Elda Tagliabue and Claudia Chiodoni and Colombo, {Mario P.}",
year = "2016",
month = "9",
day = "27",
doi = "10.1016/j.celrep.2016.08.075",
language = "English",
volume = "17",
pages = "233--248",
journal = "Cell Reports",
issn = "2211-1247",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity

AU - Sangaletti, Sabina

AU - Tripodo, Claudio

AU - Santangelo, Alessandra

AU - Castioni, Nadia

AU - Portararo, Paola

AU - Gulino, Alessandro

AU - Botti, Laura

AU - Parenza, Mariella

AU - Cappetti, Barbara

AU - Orlandi, Rosaria

AU - Tagliabue, Elda

AU - Chiodoni, Claudia

AU - Colombo, Mario P.

PY - 2016/9/27

Y1 - 2016/9/27

N2 - The extracellular matrix (ECM) contributes to the biological and clinical heterogeneity of breast cancer, and different prognostic groups can be identified according to specific ECM signatures. In high-grade, but not low-grade, tumors, an ECM signature characterized by high SPARC expression (ECM3) identifies tumors with increased epithelial-to-mesenchymal transition (EMT), reduced treatment response, and poor prognosis. To better understand how this ECM3 signature is contributing to tumorigenesis, we expressed SPARC in isogenic cell lines and found that SPARC overexpression in tumor cells reduces their growth rate and induces EMT. SPARC expression also results in the formation of a highly immunosuppressive microenvironment, composed by infiltrating T regulatory cells, mast cells, and myeloid-derived suppressor cells (MDSCs). The ability of SPARC to induce EMT depended on the localization and suppressive function of myeloid cells, and inhibition of the suppressive function MDSCs by administration of aminobisphosphonates could revert EMT, rendering SPARC-overexpressing tumor cells sensitive to Doxil. We conclude that that SPARC is regulating the interplay between MDSCs and the ECM to drive the induction of EMT in tumor cells.

AB - The extracellular matrix (ECM) contributes to the biological and clinical heterogeneity of breast cancer, and different prognostic groups can be identified according to specific ECM signatures. In high-grade, but not low-grade, tumors, an ECM signature characterized by high SPARC expression (ECM3) identifies tumors with increased epithelial-to-mesenchymal transition (EMT), reduced treatment response, and poor prognosis. To better understand how this ECM3 signature is contributing to tumorigenesis, we expressed SPARC in isogenic cell lines and found that SPARC overexpression in tumor cells reduces their growth rate and induces EMT. SPARC expression also results in the formation of a highly immunosuppressive microenvironment, composed by infiltrating T regulatory cells, mast cells, and myeloid-derived suppressor cells (MDSCs). The ability of SPARC to induce EMT depended on the localization and suppressive function of myeloid cells, and inhibition of the suppressive function MDSCs by administration of aminobisphosphonates could revert EMT, rendering SPARC-overexpressing tumor cells sensitive to Doxil. We conclude that that SPARC is regulating the interplay between MDSCs and the ECM to drive the induction of EMT in tumor cells.

KW - aminobisphosphonates

KW - Breast cancer

KW - COX-2

KW - CXCL12

KW - cyclooxygenase-2

KW - ECM

KW - EMT

KW - epithelial to mesenchymal transition

KW - extracellular matrix

KW - G-CSF

KW - GM-CSF

KW - granulocyte colony-stimulating factor

KW - granulocyte-macrophage colony-stimulating factor

KW - MDSC

KW - myeloid-derived suppressor cells

KW - SPARC

UR - http://www.scopus.com/inward/record.url?scp=84989906726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989906726&partnerID=8YFLogxK

U2 - 10.1016/j.celrep.2016.08.075

DO - 10.1016/j.celrep.2016.08.075

M3 - Article

AN - SCOPUS:84989906726

VL - 17

SP - 233

EP - 248

JO - Cell Reports

JF - Cell Reports

SN - 2211-1247

IS - 1

ER -